COTA blog

Company News

COTA and Guardant Health Collaborate Using Real-World Data to Reveal Insights into Metastatic Colon Cancer and Prevalence of Biomarker Testing

December 12, 2019
COTA Team

Research Published in JCO Precision Oncology Found Only 40 Percent of Patients with Metastatic Colon Cancer Receive Guideline-Recommended Biomarker Testing

READ MORE
Company News

COTA Presents Posters at ASH Annual Meeting, Reviewing Complexities of Generating RWD and How it Complements Traditional Clinical Trial Data

December 4, 2019
COTA Team

Research Presented Alongside MMRF and HUMC Evaluates Opportunity for RWE to Study Patient Treatment & Outcomes in Routine Cancer Care

READ MORE
Research and Technology

The Role of Data in Patient Care and Drug Development

November 25, 2019
Mike Doyle

This fall, COTA's CEO Mike Doyle attended the Healthcare Leaders Conference in Dallas, TX, and the Future of Health Data Summit 2019 in Washington, DC. In his conversations, a few key takeaways stood out around innovations related to the use of meaningful data...

READ MORE
Culture

COTA Team Member Spotlight: Tanvi Pal

November 22, 2019
COTA Team

We are pleased to recognize Tanvi Pal in this month’s Team Member Spotlight! If you’re interested in learning more about Tanvi, why she likes working at COTA and her thoughts on the future of cancer care, read on...

READ MORE
Research and Technology

How Real-World Evidence Can Validate TAILORx and Inform Cancer Care

October 22, 2019
CK Wang, MD

The TAILORx study was a major landmark in setting a new standard of care for breast cancer patients. But how well do real world treatment and outcomes mirror that of the clinical trial?

READ MORE
Mission

Video: #OurStoriesOurMission

October 17, 2019
COTA Team

During #BreastCancerAwarenessMonth, members of our team share their cancer stories and how these experiences inspire them to advance cancer care and research at COTA.

READ MORE
Research and Technology

Collaborating with our Frenemies

October 15, 2019
COTA Team

COTA’s medical and scientific teams recently participated in the 8th Annual Friends of Cancer Research Blueprint for Breakthrough Forum in Washington, DC with various stakeholders across the regulatory and RWE landscape.

READ MORE
Mission

Finding Support in Survivors’ Stories

October 11, 2019
Marquina Iliev-Piselli

While going through breast cancer treatment, Marquina Iliev-Piselli couldn’t find a book that provided the guidance & support she needed. So, she wrote her own. COTA recently connected with Marquina to learn about her diagnosis, journey, and what led her to becoming part of the support system for cancer patients.

READ MORE
Mission

#OurStoriesOurMission

October 2, 2019
COTA Team

While planning activities for breast cancer awareness month at COTA, Helena Yelovich who works on our medical team, made an impassioned request: “Don’t Ignore Stage 4.” Read more about her story on our blog.

READ MORE
Research and Technology

Summer Reading Recap: What you missed in oncology & healthcare

August 27, 2019
COTA Team

As summer is coming to a close and everyone is returning from their summer vacations, we wanted to take the opportunity to review some key moments in the news from the last few weeks.

READ MORE
Culture

COTA Team Member Spotlight: Maria Feinstein

August 22, 2019
COTA Team

We are pleased to recognize Maria Feinstein, MSN, RN, BMTCN in this month’s Team Member Spotlight! Learn more about Maria's background and her role at COTA in our latest blog.

READ MORE
Research and Technology

Initial Results of Real-World Evidence Pilot Study Published in JCO Clinical Cancer Informatics

August 6, 2019
COTA Team

Friends of Cancer Research collaborative project brings together COTA and nine other healthcare organizations & stakeholders to fuel understanding of RWE in oncology

READ MORE
Company News

COTA, Inc. Announces Headquarter Relocation to Boston for Continued Growth

August 1, 2019
COTA Team

COTA is relocating our headquarters to Boston! We are excited to immerse ourselves in a city that is rich in health technology and life science industries that align with our mission of improving cancer care.

READ MORE
Culture

Celebrating Diversity with COTA

July 30, 2019
COTA Team

Did you know COTA has a Diversity & Inclusion Committee to foster conversation, collaboration, and education between employees? Learn more about how this group recently celebrated National Celebrate Diversity Month and Pride Month, as well as COTA's support of the Title VII amicus brief.

READ MORE
Company News

COTA Welcomes Daniel Lane as Vice President for HEOR to Drive Outcomes-Based Research in Oncology

July 25, 2019
COTA Team

COTA, Inc. has named Daniel Lane as its new Vice President for Health Economics and Outcomes Research (HEOR). Learn more about what this news means for COTA!

READ MORE
Mission

Real World Cancer Stories

July 22, 2019
COTA Team

COTA hosts weekly lunch and learns where guests are invited to share their expertise or personal experiences on various topics. Recently, 35-year-old cancer survivor Tiffany Dyba joined a room full of CO10s at our NY office.

READ MORE
Company News

Behind the Brand: Unpacking Our New Look

July 8, 2019
COTA Team

If you’ve scrolled through our social channels or visited our website recently, you may have observed a different look and feel. Learn more about how our updated brand aligns with our company mission and values.

READ MORE
Culture

COTA Team Member Spotlight: Ashwin Lakshmanan

July 1, 2019
COTA Team

This month, we’re excited to recognize Ashwin Lakshmanan, Manager, Data Science and Analytics, in our latest Team Member Spotlight

READ MORE
Research and Technology

STAT+: How to Apply Real-World Evidence to Outsmart Cancer

June 25, 2019
COTA Team

Elaborating on the use cases for real-world data, Chris Boone, VP for global medical epidemiology & big data analysis at Pfizer, and Viraj Narayanan, VP of life sciences at COTA, Inc., recently co-authored a STAT+ article that explores how real-world evidence can be used to fuel precision medicine and disrupt increasingly outdated clinical trial models.

READ MORE
Research and Technology

ASCO 2019 - The Reaffirmation of Real-World Evidence in Cancer Care

June 13, 2019
Mike Doyle

The CO10s are back from ASCO 2019! See what Mike Doyle, COTA's CEO, took away from this year's conference as it relates to the use of real-world data and evidence in cancer care.

READ MORE
Company News

COTA News – Multiple Myeloma Research Foundation Launches CureCloud™ to Advance Precision Medicine

June 12, 2019
COTA Team

The MMRF announced they are launching CureCloud™, a centralized data hub that generates, aggregates and visualizes data to advance precision medicine to patients living with multiple myeloma. See how COTA is supporting this program!

READ MORE
Culture

COTA Team Member Spotlight: CC Obi-Gwacham

June 5, 2019
COTA Team

Learn more about CC Obi-Gwacham in the latest COTA Team Member Spotlight!

READ MORE
Company News

COTA Signs Research Collaboration Agreement With The U.S. Food and Drug Administration

May 29, 2019
COTA Team

Collaboration Aims to Study Variation in Cancer Treatment Patterns by Extracting and Analyzing Real-World Data

READ MORE
Research and Technology

ASCO 2019 - How Precision Medicine and RWE Can Shape the Future of Oncology Care

May 27, 2019
COTA Medical Leadership

In advance of the 2019 ASCO Annual Meeting, members of COTA's medical leadership team offer predictions for this year's conference on topics including the role of precision medicine and RWE in oncology care.

READ MORE
Culture

COTA Team Member Spotlight: Emily Di Capua

April 8, 2019
COTA Team

As a company that builds solutions that analyze real-world data to deliver clinically relevant insights that improve cancer care, we want to step back and feature the wonderful COTA team members (called CO10s) who are helping us achieve this goal. This week, we're featuring Emily Di Capua, our VP of Strategic Initiatives.

READ MORE
Research and Technology

The FDA’s History with RWE – and Continued Momentum from Dr. Sharpless

March 28, 2019
Mike Doyle

Earlier this month, Dr. Scott Gottlieb, the popular FDA Commissioner, announced he is resigning. COTA's blog explores what this means for the future of RWE and the FDA.

READ MORE
Culture

COTA Team Member Spotlight: Kaeleigh Farrish

March 12, 2019
COTA Team

As a company that builds solutions that analyze real-world data to deliver clinically relevant insights that improve cancer care, we want to step back and feature the wonderful COTA team members (called CO10s) who are helping us achieve this goal. The first CO10 that we are featuring in this spotlight series is Kaeleigh Farrish, COTA’s Director of Operations & Delivery Services!

READ MORE
Research and Technology

Reevaluating Expectations for HIT’s Biggest Bonanza

February 26, 2019
Mike Doyle

COTA's CEO Mike Doyle highlights his key takeaways from HIMSS19 around data stockpiling, thinking like consumers, and precision medicine.

READ MORE
Research and Technology

The Cancer Market is Booming – How Does That Impact Care?

February 7, 2019
Viraj Narayanan

It’s no secret that oncology care is at a turning point, but what does this mean for patient care? COTA's VP of Life Sciences Viraj Narayanan explores the impact and what we can expect in the future.

READ MORE
Research and Technology

Cancer Death Rate Hits 25 Years of Decline - What's Changing?

January 22, 2019
COTA Team

The American Cancer Society announced promising news to start off 2019 - the overall nationwide cancer death rate has fallen continuously over the last 25 years. What changes have led to this decline?

READ MORE
Research and Technology

HIMSS19: The Importance of Data and Managing Expectations

January 8, 2019
Mike Doyle

COTA's CEO Mike Doyle reflects on what to expect from HIMSS19. In healthcare, there is so much promise and opportunity for technology to deliver the best care possible, so how can we set the right expectations for new tech?

READ MORE
Research and Technology

What’s ahead in 2019? 4 Predictions from COTA’s Andrew Norden

December 27, 2018
Andrew Norden, M.D.

In today's dynamic healthcare environment, what can we expect in oncology in 2019? Dr. Andrew Norden, COTA's Chief Medical Officer, offers a few predictions to note in the fields of real-world evidence, cancer treatment, and clinical research.

READ MORE
Research and Technology

Changing How We Treat Cancer, Beginning with Drug Approvals

December 17, 2018
Andrew Norden, M.D.

Earlier this month, the FDA approved the drug Vitrakvi to treat a wide range of cancers. Andrew Norden, M.D., COTA's Chief Medical Officer, discusses what this means for the future of cancer care and precision medicine.

READ MORE
Company News

CEO Corner: Mike Doyle’s First Month at COTA

December 3, 2018
COTA Team

New CEO Mike Doyle reflects on his first month at COTA, the impact of precision medicine in oncology, and the clinical value of real world evidence.

READ MORE
Research and Technology

Meet Cota at ASCO's Annual Meeting and eyeforpharma's Oncology Market Access & Pricing Summit

May 31, 2017
COTA Team

Meet the Cota team as we hit the road to sponsor two major oncology events this summer.

READ MORE
Subscribe to receive the latest posts
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

Bringing clarity
to cancer

We are working to ensure that everyone touched by cancer has a clear path to the right care.